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Rationale: Patients with chronic heart failure (CHF) have reduced exercise capacity, a strong predictor of long-term events. Anemia also is 
prevalent in CHF, predicts outcome and may influence exercise performance. To what extent anemia and exercise performance interact in CHF 
patients is unknown.
Aim: To study the association between haemoglobin (Hb) level and cardiopulmonary performance in CHF.
Methods: The HF-ACTION study evaluated the effects of exercise training on outcome and 1730 patients from that trial were included in this 
analysis. The association between Hb, anemia status and cardiopulmonary performance, specifically, peak VO2, VO2 at ventilator threshold (VT), and 
VE/VCO2 slope alone and in combination with other clinical predictors was explored.
Results: The population of patients with Hb data was similar to the overall HF-ACTION population. Using the WHO definition of anemia, 510 
(29%) patients were anemic and 1220 (71%) were not. Anemia was substantially more prevalent in older, black and in NYHA functional class III-IV 
patients. Anemic patients were more likely diabetic, to have renal dysfunction, and lower functional capacity. With regard to exercise parameters, 
anemic patients had a 2.2 mL/kg/min lower median peak VO2, a higher VE/VCO2 slope (1.8 units) and a lower VO2 at VT (1.2 mL/kg/min). 
Plasma Hb correlated with all measures of exercise capacity: peak VO2 (r=0.262), VT (r=0.254) and VE/VCO2 slope (r=-0.129), (all p <0.001). For 
each difference in Hb of 1g/dL there was an associated greater peak VO2 by 0.74 mL/min/kg (0.33 mL/min/kg when adjusted for covariates). In 
multivariable analysis using prospective determined covariates related to baseline CPX variables, these relations became weaker (r2 = 0.021, 0.035, 
0.008 for peak VO2, VT and VE/VCO2 slope respectively, all p < 0.001)
Conclusions: Although the role of anemia should not be overlooked, its role in determining exercise responses seems to be weaker than the 
contribution of other covariates, although these other factors may not be directly modifiable. Further studies are warranted to determine if an 
increase in Hb may prove effective in increasing exercise capacity and lowering VE/VCO2 in these patients.
